|
1
|
Iczkowski KA and Czaja RC: Eosinophilic
kidney tumors: Old and new. Arch Pathol Lab Med. 143:1455–1463.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kryvenko ON, Jorda M, Argani P and Epstein
JI: Diagnostic approach to eosinophilic renal neoplasms. Arch
Pathol Lab Med. 138:1531–1541. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Guinamard R, Sallé L and Simard C: The
non-selective monovalent cationic channels TRPM4 and TRPM5. Adv Exp
Med Biol. 704:147–171. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Vennekens R and Nilius B: Insights into
TRPM4 function, regulation and physiological role. Handb Exp
Pharmacol. 179:269–285. 2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Prevarskaya N, Skryma R, Bidaux G,
Flourakis M and Shuba Y: Ion channels in death and differentiation
of prostate cancer cells. Cell Death Differ. 14:1295–1304.
2007.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kappel S, Stokłosa P, Hauert B,
Ross-Kaschitza D, Borgström A, Baur R, Galván JA, Zlobec I and
Peinelt C: TRPM4 is highly expressed in human colorectal tumor buds
and contributes to proliferation, cell cycle, and invasion of
colorectal cancer cells. Mol Oncol. 13:2393–2405. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Holzmann C, Kappel S, Kilch T, Jochum MM,
Urban SK, Jung V, Stöckle M, Rother K, Greiner M and Peinelt C:
Transient receptor potential melastatin 4 channel contributes to
migration of androgen-insensitive prostate cancer cells.
Oncotarget. 6:41783–41793. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gao Y and Liao P: TRPM4 channel and
cancer. Cancer Lett. 454:66–69. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Shapovalov G, Ritaine A, Skryma R and
Prevarskaya N: Role of TRP ion channels in cancer and
tumorigenesis. Semin Immunopathol. 38:357–369. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Monteith GR, McAndrew D, Faddy HM and
Roberts-Thomson SJ: Calcium and cancer: Targeting Ca2+
transport. Nat Rev Cancer. 7:519–530. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Schattling B, Steinbach K, Thies E, Kruse
M, Menigoz A, Ufer F, Flockerzi V, Brück W, Pongs O, Vennekens R,
et al: TRPM4 cation channel mediates axonal and neuronal
degeneration in experimental autoimmune encephalomyelitis and
multiple sclerosis. Nat Med. 18:1805–1811. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Tosun C, Kurland DB, Mehta R, Castellani
RJ, deJong JL, Kwon MS, Woo SK, Gerzanich V and Simard JM:
Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and
cognitive impairment in subarachnoid hemorrhage. Stroke.
44:3522–3528. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mehta RI, Tosun C, Ivanova S, Tsymbalyuk
N, Famakin BM, Kwon MS, Castellan RJ, Gerzanich V and Simard JM:
Sur1-Trpm4 cation channel expression in human cerebral infarcts. J
Neuropathol Exp Neurol. 74:835–849. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Qin F, Lao L, Huang M, Tan H, Jin X, Ma X
and Zeng J: Evaluation of the TRPM protein family as potential
biomarkers for various types of human cancer using public database
analyses. Exp Ther Med. 20:770–785. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Holzmann C, Kappel S, Kilch T, Jochum MM,
Urban SK, Jung V, Stöckle M, Rother K, Griner M and Peinelt C:
Transient receptor potential melastatin 4 channel contributes to
migration of androgen-insensitive prostate cancer cells.
Oncotarget. 8:41783–41793. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ceylan GG, Önalan EE, Kuloğlu T, Aydoğ G,
Keleş İ, Tonyal Ş and Ceylan C: Potential role of
melastatin-related transient receptor potential cation channel
subfamily M gene expression in the pathogenesis of urinary bladder
cancer. Oncol Lett. 12:5235–5239. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sozucan Y, Kalender ME, Sari I, Suner A,
Oztuzcu S, Arman K, Yumrutas O, Bozgeyik I, Cengiz B, Igci YZ, et
al: TRP genes family expression in colorectal cancer. Exp Oncol.
37:208–212. 2015.PubMed/NCBI
|
|
18
|
Narayan G, Bourdon V, Chaganti S,
Arias-Pulido H, Nandula SV, Rao PH, Gissmann L, Dürst M, Schneider
A, Pothuri B, et al: Gene dosage alterations revealed by cDNA
microarray analysis in cervical cancer: Identification of candidate
amplified and overexpressed genes. Genes Chromosomes Cancer.
40:373–384. 2007.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Loo SK, Ch'ng ES, Md Salleh MS, Banham AH,
Pedersen LM, Møller MB, Green TM and Wong KK: TRPM4 expression is
associated with activated B cell subtype and poor survival in
diffuse large B cell lymphoma. Histopathology. 71:98–111.
2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chen J, Luan Y, Yu R, Zhang Z, Zhang J and
Wang W: Transient receptor potential (TRP) channels, promising
potential diagnostic and therapeutic tools for cancer. Biosci
Trends. 8:1–10. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Ashida S, Nakagawa H, Katagiri T, Furihata
M, Liizumi M, Anazawa Y, Tsunoda T, Takata R, Kasahara K, Miki T,
et al: Molecular features of the transition from prostatic
intraepithelial neoplasia (PIN) to prostate cancer: Genome-wide
gene-expression profiles of prostate cancers and PINs. Cancer Res.
64:5963–5972. 2004.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Berg KD, Soldini D, Jung M, Dietrich D,
Stephan C, Jung K, Dietel M, Vainer B and Kristiansen G: TRPM4
protein expression in prostate cancer: A novel tissue biomarker
associated with risk of biochemical recurrence following radical
prostatectomy. Virchows Arch. 468:345–355. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Trpkov K and Hes O: New and emerging renal
entities: A perspective post-WHO 2016 classification.
Histopathology. 74:31–59. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Liu L, Qian J, Singh H, Meiers I, Zhou X
and Bostwick DG: Immunohistochemical analysis of chromophobe renal
cell carcinoma, renal oncocytoma, and clear cell carcinoma: An
optimal and practical panel for differential diagnosis. Arch Pathol
Lab Med. 131:1290–1297. 2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Delahunt B and Eble JN: Papillary renal
cell carcinoma: A clinicopathologic and mmunohistochemical study of
105 tumors. Mod Pathol. 10:537–544. 1997.PubMed/NCBI
|
|
26
|
Hong X and Yu JJ: MicroRNA-150 suppresses
epithelial mesenchymal transition, invasion and metastasis in
prostate cancer through the TRPM4-mediated β-catenin signaling
pathway. Am J Physiol Cell Physiol. 316:C463–C480. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wong KK and Hussain FA: TRPM4 is
overexpressed in breast cancer associated with estrogen response
and epithelial-mesenchymal transition gene sets. PLoS One.
15(e0233884)2020.PubMed/NCBI View Article : Google Scholar
|
